Trends in Ciprofloxacin Nonsusceptibility and Levofloxacin Resistance among Streptococcus pneumoniae Isolates in North America

This publication has 11 references indexed in Scilit:

• Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis
  Antimicrobial Agents and Chemotherapy, 2001
• Risk Factors for Acquisition of Levofloxacin-Resistant Streptococcus pneumoniae: A Case-Control Study
  Clinical Infectious Diseases, 2001
• Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States
  Antimicrobial Agents and Chemotherapy, 2000
• In Vitro Activity of Newer Fluoroquinolones for Respiratory Tract Infections and Emerging Patterns of Antimicrobial Resistance: Data from the SENTRY Antimicrobial Surveillance Program
  Clinical Infectious Diseases, 2000
• Fluoroquinolone resistance in Streptococcus pneumoniae.
  1999
• Fluoroquinolone Resistance inStreptococcus pneumoniae
  New England Journal of Medicine, 1999
• Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.
  1999
• Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in Canada
  New England Journal of Medicine, 1999
• Comparative antimicrobial activity of trovafloxacin tested against 3049 streptococcus pneumoniae isolates from the 1997–1998 respiratory infection season
  Diagnostic Microbiology and Infectious Disease, 1998
• Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
  Antimicrobial Agents and Chemotherapy, 1998